Skip to main content
. 2016 Jul 26;30(11):3714–3725. doi: 10.1096/fj.201600360R

Figure 2.

Figure 2.

Plasma DHA metabolites influenced by DPA supplementation. A) Plasma concentration of CYP-pathway–derived DHA epoxides (EpDPE) and downstream vicinal diols (DiHDoPE) in response to DPA supplementation. B) Plasma concentration of MaR1 in response to supplementation with OO, EPA, or DPA. C) Plasma concentrations of RvD1 in response to supplementation with OO, EPA, or DPA. Value are means ± sem. *P < 0.05 vs. d 0 within respective supplementation period; #P < 0.05 vs. placebo OO supplementation at the same time point.